InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Nolan Garry Ph.D., Director. Director active across 1 companies, notably Akoya Biosciences, Inc.. In total, 2 filings have been published. Total volume traded: €558k. The latest transaction was filed on 9 December 2021 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€279,19425,000 shares@ €11.1678100.0% of flow
Common Stock
SEC:0001104659-21-149196·
€279,19425,000 shares@ €11.167850.0% of flow
Common Stock
SEC:0001104659-21-149196:0·
2 of 2 declarations
About Nolan Garry Ph.D.
Garry Ph.D. Nolan serves as a Director of Akoya Biosciences, Inc. As a board member, he contributes to the strategic direction of the company and important decision-making regarding its operations. Garry brings valuable scientific expertise, assisting Akoya in innovating and growing within the biotechnology sector. His role is essential for ensuring the company's long-term success.
